Skip to main content
Equibles

Roshawn Blunt

Board Member

OnKure Therapeutics, Inc. (OKUR)

Equibles does not estimate personal net worth.

About Roshawn Blunt

Roshawn Blunt is recorded as Board Member at OnKure Therapeutics, Inc. (OKUR) since August 2, 2022. OnKure Therapeutics, Inc. reported in an 8-K filed August 2, 2022 that Roshawn Blunt was appointed Class I director, effective August 2, 2022. OnKure Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at OnKure Therapeutics, Inc. includes Nicholas A. Saccomano (CEO and Board Member), Nicholas A. Saccomano, Ph.D. (CEO), Nicholas Saccomano (CEO and Board Member) and 7 others.

“On August 2, 2022, the Board of Directors (the "Board") of Reneo Pharmaceuticals, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Roshawn Blunt as a Class I director of the Company, with a term of office expiring at the 2025 annual meeting of stockholders.”
OnKure Therapeutics, Inc. Form 8-K, filed August 2, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at OnKure Therapeutics, Inc.

Recent activity